Thursday, September 10, 2020 11:56:50 AM
Fee Available Updated
1.0 % 1,100,000 2020-09-10 11:45:03
1.0 % 1,100,000 2020-09-10 11:30:03
1.0 % 1,100,000 2020-09-10 11:15:03
1.0 % 1,100,000 2020-09-10 11:00:03
1.0 % 1,100,000 2020-09-10 10:45:02
1.0 % 1,100,000 2020-09-10 10:30:02
1.0 % 1,100,000 2020-09-10 10:15:02
1.1 % 1,100,000 2020-09-10 10:00:03
1.1 % 1,200,000 2020-09-10 09:45:02
1.1 % 1,200,000 2020-09-10 09:30:03
1.1 % 1,200,000 2020-09-10 09:15:02
1.1 % 1,200,000 2020-09-10 09:00:02
1.1 % 1,000,000 2020-09-09 16:45:03
1.1 % 1,000,000 2020-09-09 16:30:03
1.1 % 1,000,000 2020-09-09 16:15:02
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM